Chimeric polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

US9676830B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9676830-B2
Application numberUS-201113883923-A
CountryUS
Kind codeB2
Filing dateNov 18, 2011
Priority dateNov 18, 2010
Publication dateJun 13, 2017
Grant dateJun 13, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to chimeric GH61 polypeptides having cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the chimeric GH61 polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the chimeric GH61 polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated chimeric GH61 polypeptide having cellulolytic enhancing activity, comprising: (a) a first GH61 polypeptide fragment at the N-terminal end of the chimeric GH61 polypeptide, wherein the first GH61 polypeptide fragment is selected from the group consisting of (i) a polypeptide fragment having at least 95% sequence identity to amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78; and (ii) a polypeptide fragment comprising amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78; (b) a second GH61 polypeptide fragment at the C-terminal end of the first GH61 polypeptide fragment, wherein the second GH61 polypeptide fragment is selected from the group consisting of (i) a polypeptide fragment having at least 95% sequence identity to amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94; and (ii) a polypeptide fragment comprising amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94; and (c) a third GH61 polypeptide fragment at the C-terminal end of the second GH61 polypeptide fragment, wherein the third GH61 polypeptide fragment is selected from the group consisting of (i) a polypeptide fragment having at least 95% sequence identity to amino acids 208 to 249 of the polypeptide of SEQ ID NO: 78; and (ii) a polypeptide fragment comprising amino acids 208 to 249 of the polypeptide of SEQ ID NO: 78. 2. The chimeric GH61 polypeptide of claim 1 , wherein the first GH61 polypeptide fragment comprises amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78. 3. The chimeric GH61 polypeptide of claim 1 , wherein the second GH61 polypeptide fragment comprises amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94. 4. The chimeric GH61 polypeptide of claim 1 , wherein the third GH61 polypeptide fragment comprises amino acids 208 to 249 of the polypeptide of SEQ ID NO: 78. 5. The chimeric GH61 polypeptide of claim 1 , which comprises amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78 as the first GH61 polypeptide fragment at the N-terminal end of the chimeric GH61 polypeptide, amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94 as the second GH61 polypeptide fragment at the C-terminal end of the first GH61 polypeptide fragment, and amino acids 208 to 249 of the polypeptide of SEQ ID NO: 78 as the third GH61 polypeptide fragment at the C-terminal end of the second GH61 polypeptide fragment. 6. The chimeric GH61 polypeptide of claim 1 , which comprises the mature polypeptide of SEQ ID NO: 144. 7. An isolated polynucleotide encoding the chimeric GH61 polypeptide of claim 1 . 8. A host cell comprising the polynucleotide of claim 7 . 9. A method of producing a chimeric GH61 polypeptide having cellulolytic enhancing activity, comprising: (a) cultivating the host cell of claim 8 under conditions suitable for the expression of the chimeric GH61 polypeptide; and (b) recovering the chimeric GH61 polypeptide. 10. A transgenic plant, plant part or plant cell transformed with the polynucleotide of claim 7 encoding the chimeric GH61 polypeptide. 11. A method of producing the chimeric GH61 polypeptide of claim 1 , comprising: (a) cultivating a transgenic plant or a plant cell comprising a polynucleotide encoding the chimeric GH61 polypeptide under conditions conducive for production of the chimeric GH61 polypeptide; and (b) recovering the chimeric GH61 polypeptide. 12. A method for degrading or converting a cellulosic material, comprising: treating the cellulosic material with an enzyme composition comprising the chimeric GH61 polypeptide of claim 1 . 13. The method of claim 12 , further comprising recovering the degraded or converted cellulosic material. 14. The method of claim 12 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, a polypeptide having cellulolytic enhancing activity, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin. 15. The method of claim 12 , wherein the converted cellulosic material is a sugar. 16. A method for producing a fermentation product, comprising: (a) saccharifying a cellulosic material with an enzyme composition comprising the chimeric GH61 polypeptide of claim 1 ; (b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and (c) recovering the fermentation product from the fermentation. 17. The method of claim 16 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, a polypeptide having cellulolytic enhancing activity, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin. 18. A method of fermenting a cellulosic material, comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising the chimeric GH61 polypeptide of claim 1 . 19. The method of claim 18 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, a polypeptide having cellulolytic enhancing activity, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin. 20. The method of claim 18 , wherein the fermenting of the cellulosic material produces a fermentation product. 21. The method of claim 20 , further comprising recovering the fermentation product from the fermentation. 22. A whole broth formulation or cell culture composition comprising the chimeric GH61 polypeptide of claim 1 . 23. The chimeric GH61 polypeptide of claim 1 , wherein the first GH61 polypeptide fragment has at least 96% sequence identity to amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78. 24. The chimeric GH61 polypeptide of claim 1 , wherein the first GH61 polypeptide fragment has at least 97% sequence identity to amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78. 25. The chimeric GH61 polypeptide of claim 1 , wherein the first GH61 polypeptide fragment has at least 98% sequence identity to amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78. 26. The chimeric GH61 polypeptide of claim 1 , wherein the first GH61 polypeptide fragment has at least 99% sequence identity to amino acids 22 to 84 of the polypeptide of SEQ ID NO: 78. 27. The chimeric GH61 polypeptide of claim 1 , wherein the second GH61 polypeptide fragment has at least 96% sequence identity to amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94. 28. The chimeric GH61 polypeptide of claim 1 , wherein the second GH61 polypeptide fragment has at least 97% sequence identity to amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94. 29. The chimeric GH61 polypeptide of claim 1 , wherein the second GH61 polypeptide fragment has at least 98% sequence identity to amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94. 30. The chimeric GH61 polypeptide of claim 1 , wherein the second GH61 polypeptide fragment has at least 99% sequence identity to amino acids 85 to 207 of the polypeptide of SEQ ID NO: 94. 31. The chimeric GH61 polypeptide of claim 1 , wherein the third GH61 polypeptide fragment has at leas

Assignees

Inventors

Classifications

  • C12N9/0004Primary

    Oxidoreductases (1.) · CPC title

  • C07K14/38Primary

    from Aspergillus · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9676830B2 cover?
The present invention relates to chimeric GH61 polypeptides having cellulolytic enhancing activity. The present invention also relates to polynucleotides encoding the chimeric GH61 polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the chimeric GH61 polypeptides.
Who is the assignee on this patent?
Wogulis Mark, Sweeney Matthew, Heu Tia, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12N9/0004. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).